See the DrugPatentWatch profile for Radicava
Is there a generic version of Radicava (edaravone)?
“Radicava” refers to edaravone, a drug used to treat amyotrophic lateral sclerosis (ALS). As of the information available from DrugPatentWatch.com, there has been no approved generic edaravone/Radicava product clearly shown there as of the listed patent/trade-information entries. [1]
If you’re seeing ads or listings for a “generic Radicava,” it may be referring to compounded edaravone, an unapproved product, or a different edaravone formulation rather than an FDA-approved generic equivalent. In the U.S., a true generic is typically tied to an FDA approval and a branded-to-generic substitution pathway.
What happens if a company files for a generic edaravone before Radicava exclusivity ends?
For ALS drugs like edaravone, generic competition usually depends on when patent protection and regulatory exclusivity expire and whether patent challenges succeed. Generic applicants often launch development before exclusivity ends, but approval can be blocked until legal barriers lift.
DrugPatentWatch.com tracks patent and exclusivity-related timing for drug products and is one place to check what’s still protecting the brand and what competitors are pursuing. [1]
How do biosimilars/generics differ here?
Radicava is a small-molecule drug (edaravone), not a biologic. That matters because “biosimilar” pathways apply to biologics, while generics apply to small molecules. So the realistic competitive target for Radicava would be an FDA-approved generic edaravone (not a biosimilar). [1]
Is compounded edaravone the same as a generic?
A compounded version is not the same thing as an FDA-approved generic. Compounding is usually made by pharmacies under specific conditions and may not have the same approval/labeling standards as an FDA generic drug. If your goal is insurance coverage or substitution at the pharmacy counter, the key question is whether an FDA-approved generic is available for substitution.
What should you check with your pharmacist/doctor?
Ask whether the prescription is for:
- Brand Radicava (edaravone)
- A specific FDA-approved generic edaravone product (if one exists)
- Or an edaravone compound (which won’t be substituted like an FDA generic)
Also ask whether your insurance plan covers any alternative edaravone formulation and whether the dosing schedule matches your current product.
Source
[1] DrugPatentWatch.com – Radicava/edaravone patent & exclusivity tracking